Publications by authors named "Therese Juntti"

Claim this Profile
P
Preclinical activity of melflufen (J1) in ovarian cancer.
Charlotte Carlier, Sara Strese, Kristina Viktorsson, Ebba Velander, Peter Nygren, Therese Juntti

Oncotarget· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer.
Ghazal Efazat, Metka Novak, Vitaliy O Kaminskyy, Luigi De Petris, Lena Kanter, Therese Juntti

Oncotarget· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melphalan-flufenamide is cytotoxic and potentiates treatment with chemotherapy and the Src inhibitor dasatinib in urothelial carcinoma.
Kristina Viktorsson, Carl-Henrik Shah, Therese Juntti, Petra Hååg, Katarzyna Zielinska-Chomej

Mol Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BDC12-4.1 T-cell receptor transgenic insulin-specific CD4 T cells are resistant to in vitro differentiation into functional Foxp3+ T regulatory cells.
Ghanashyam Sarikonda, Georgia Fousteri, Sowbarnika Sachithanantham, Jacqueline F Miller, Amy Dave, Therese Juntti

PLoS One· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphoprotein analysis reveals MEK inhibition as a way to target non-small cell lung cancer tumor initiating cells.
Lovisa Lundholm, Petra Hååg, Therese Juntti, Rolf Lewensohn, Kristina Viktorsson

Int J Radiat Biol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Following the fate of one insulin-reactive CD4 T cell: conversion into Teffs and Tregs in the periphery controls diabetes in NOD mice.
Georgia Fousteri, Jean Jasinski, Amy Dave, Maki Nakayama, Philippe Pagni, Therese Juntti

Diabetes· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of autoimmune diabetes in the absence of detectable IL-17A in a CD8-driven virally induced model.
Tom L Van Belle, Enric Esplugues, Jeanette Liao, Therese Juntti, Richard A Flavell

J Immunol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased memory conversion of naïve CD8 T cells activated during late phases of acute virus infection due to decreased cumulative antigen exposure.
Georgia Fousteri, Amy Dave, Amy Juedes, Therese Juntti, Bret Morin

PLoS One· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment.
Tom L Van Belle, Therese Juntti, Jeanette Liao, Matthias G von Herrath

J Autoimmun· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal effect of CD103 expression on the control of a chronic antiviral immune response.
Georgia Fousteri, Amy Dave, Therese Juntti, Bret Morin, Malina McClure

Viral Immunol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD103 is dispensable for anti-viral immunity and autoimmunity in a mouse model of virally-induced autoimmune diabetes.
Georgia Fousteri, Amy Dave, Therese Juntti, Matthias von Herrath

J Autoimmun· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis